The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects

[1]  A W Kelman,et al.  Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring. , 1983, Therapeutic drug monitoring.

[2]  G. Tucker,et al.  Time-dependent kinetics of lignocaine in the isolated perfused rat liver , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  Malcolm Rowland,et al.  Pharmacokinetics of lidocaine and its deethylated metabolite: Dose and time dependency studies in man , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  J. P. Shea,et al.  Influence of long‐term infusions on lidocaine kinetics , 1982, Clinical pharmacology and therapy.

[5]  G. Wagner,et al.  On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. , 1982, British journal of clinical pharmacology.

[6]  A. Kelman,et al.  Systolic time interval v heart rate regression equations using atropine: reproducibility studies. , 1981, British Journal of Clinical Pharmacology.

[7]  R. Nation,et al.  High-performance liquid chromatographic method for the simultaneous determination of lidocaine and its N-dealkylated metabolites in plasma. , 1979, Journal of chromatography.

[8]  N. Benowitz,et al.  Clinical Pharmacokinetics of Lignocaine , 1978, Clinical pharmacokinetics.

[9]  Y. Latour,et al.  Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. , 1977, Annals of internal medicine.

[10]  J. LeLorier,et al.  Effect of the duration of infusion on the disposition of lidocaine in dogs. , 1977, The Journal of pharmacology and experimental therapeutics.

[11]  R. Nation,et al.  Lignocaine kinetics in cardiac patients and aged subjects. , 1977, British journal of clinical pharmacology.

[12]  L. Prescott,et al.  Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. , 1976, British medical journal.

[13]  P. Meffin,et al.  Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite , 1975, Clinical pharmacology and therapeutics.

[14]  A. Atkinson,et al.  Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide , 1975, Clinical pharmacology and therapeutics.

[15]  R. Burney,et al.  Anti-arrhythmic effects of lidocaine metabolites. , 1974, American heart journal.

[16]  L. Prescott,et al.  Lignocaine metabolism in man. , 1973, British journal of pharmacology.

[17]  K. Melmon,et al.  DISPOSITION KINETICS OF LIDOCAINE IN NORMAL SUBJECTS * , 1971, Annals of the New York Academy of Sciences.

[18]  A. Beckett,et al.  The metabolism and excretion of lignocaine in man , 1966 .

[19]  R. Kawai,et al.  Precursor-metabolite interaction in the metabolism of lidocaine. , 1984, Journal of pharmaceutical sciences.